We are monitoring the impact of COVID-19 on Latin America Injectable Drug Delivery Market Get in touch with us for detailed analysis Know More
Share on

Latin America Injectable Drug Delivery Market Research Report – Segmented By Device Type, Formulation, Therapeutic Use, End User, & Country (Mexico, Brazil, Argentina, Chile and Rest of Latin America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 2020
Pages: 145

Latin America Injectable Drug Delivery Market Size (2022 to 2027)

The size of the Latin America Injectable Drug Delivery Market was valued at USD 5972.87 million in 2022. It is further estimated to be growing at a CAGR of 11.32%, to reach USD 10210.56 million by 2027.

One of the major factors driving the injectable drug delivery market in the Latin American region is that healthcare infrastructure in Brazil, Mexico, and Argentina has vastly improved in recent years. These countries are also thought to have strong growth potential. These countries' vast populations are in desperate need of specialized medicine delivery technologies. This is a powerful incentive for government officials and local pharmaceutical businesses to work toward the widespread adoption of these systems.

The increased need for vaccinations, insulin, human growth hormone, and many other modern medicines used to treat cancer and other chronic conditions is another significant factor contributing to the market's growth. Furthermore, because biologics are mostly provided via injection, the injectable medication delivery and prefilled syringe markets are projected to experience significant growth in the future years. In addition, the growing demand for biosimilar and generic injectables, quick technological breakthroughs and new product releases, and strong growth in the biologics industry are expected to provide considerable growth possibilities.

However, there have been multiple products recalls in the injectable medicine delivery technology sector in recent years. Recalls can happen on their own or as a result of regulatory involvement. Injectables have also been recalled due to contamination from inorganic materials such as glass, silicone, stainless steel, and improper vial filling. During the development phase, usability issues must be discovered and solved. The presence of visible foreign matter during retention sample testing in injectables might have serious health repercussions, including permanent impairment of a body function, blood vessel injury, and obstruction. If a product is recalled, the process of collecting and replacing the defective goods can result in significant losses for a firm or manufacturer. These massive losses will influence the company's revenue and market share, which will have an impact on the broader market.

This research report on the Latin America Injectable Drug Delivery Market has been segmented and sub-segmented into the following categories:

By Device Type: 

  • Self-Injection Devices
  • Conventional Devices

By Formulation: 

  • Conventional Drug Delivery
  • Novel Drug Delivery

By Therapeutic use: 

  • Autoimmune Disorders
  • Hormonal Disorders
  • Oncology

By End User: 

  • Hospitals
  • Homecare Settings
  • Research Institutes
  • Clinical Laboratories

By Country: 

  • Mexico
  • Brazil
  • Argentina
  • Chile
  • Rest of Latin America

Due to the widespread acceptance of sophisticated injectable medicine delivery and the growing patient population, the Latin American market is expected to register a promising share in the global market during the forecast period.

In Latin America, the Brazilian market is predicted to dominate during the forecast period, whereas Mexico and Argentina are estimated to register healthy growth rates.

KEY MARKET PLAYERS:

A few of the noteworthy companies operating in Latin America Injectable drug delivery market profiled in the report is Antares Pharmaceuticals Ltd, Baxter International, Becton Dickinson Company, Elcam Medical, Eli Lily and Company, Unilife Corporation, and West Pharmaceutical Inc.

1.Introduction                    

                1.1 Market Definition      

                1.2 Study Deliverables    

                1.3 Base Currency, Base Year and Forecast Periods            

                1.4 General Study Assumptions  

2. Research Methodology

                2.1 Introduction                 

                2.2 Research Phases        

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design           

                2.4 Study Timeline            

3. Overview                         

                3.1 Executive Summary  

                3.2 Key Inferences           

                3.3 Epidemology                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                      

                4.1 Market Drivers            

                4.2 Market Restraints      

                4.3 Key Challenges           

                4.4 Current Opportunities in the Market                

5. Market Segmentation   

                5.1 Device Type                 

                                5.1.1 Introduction                                           

                                5.1.2 Self-injection Devices                                         

                                5.1.3  Conventional Devices                                        

                                5.1.4  Y-o-Y Growth Analysis, By Device Type                                      

                                5.1.5  Market Attractiveness Analysis, By Device Type                                    

                                5.1.6  Market Share Analysis, By Device Type                                     

                5.2 Formulation                 

                                5.2.1 Introduction                                           

                                5.2.2 Conventional Drug Delivery                                             

                                5.2.3  Novel Drug Delivery                                           

                                5.2.4 Y-o-Y Growth Analysis, By Formulation                                       

                                5.2.5 Market Attractiveness Analysis, By Formulation                                     

                                5.2.6 Market Share Analysis, By Formulation                                      

                5.3 Therapeutic Use         

                                5.3.1 Introduction                                           

                                5.3.2 Autoimmune Disorders                                     

                                5.3.3 Hormonal Disorders                                            

                                5.3.4 Oncology                                 

                                5.3.5 Y-o-Y Growth Analysis, By Therapeutic Use

                                5.3.6  Market Attractiveness Analysis, By Therapeutic Use                                           

                                5.3.7  Market Share Analysis, By Therapeutic Use                                             

                5.4 End-user

                                5.4.1 Introduction                                           

                                5.4.2 Hospitals                                  

                                5.4.3 Homecare Settings

                                5.4.4 Research Institutes                                             

                                5.4.5 Clinical Laboratories                                            

                                5.4.6 Other                                        

                                5.4.7 Y-o-Y Growth Analysis, By End-user

                                5.4.8  Market Attractiveness Analysis, By End-user

                                5.4.9  Market Share Analysis, By End-user

6. Geographical Analysis   

                6.1 Introduction                 

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

  6.1.3.1 By Geographical Area                     

  6.1.3.2 By Device Type                  

  6.1.3.3 By Formulation                  

  6.1.3.4 By Therapeutic Use                         

  6.1.3.5 By End-user

                                6.1.4  Market Attractiveness Analysis                                     

  6.1.4.1 By Geographical Area                     

  6.1.4.2 By Device Type                  

  6.1.4.3 By Formulation                  

  6.1.4.4 By Therapeutic Use                         

  6.1.4.5 By End-user

                                6.1.5  Market Share Analysis                                      

  6.1.5.1 By Geographical Area                     

  6.1.5.2 By Device Type                  

  6.1.5.3 By Formulation                  

  6.1.5.4 By Therapeutic Use                         

  6.1.5.5 By End-user

                6.2 Brazil               

                6.3 Mexico           

                6.4 Rest of Latin America               

7.Strategic Analysis                          

                7.1 PESTLE analysis           

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry                                     

8.Market Leaders' Analysis                           

                8.1 Alkermes Inc.              

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Bend Research            

                8.3 BIND Biosciences Inc.               

                8.4 Endocyte       

                8.5 Genentech Inc.           

                8.6 MicroCHIPS Inc.          

                8.7 Pearl Therapeutics Inc.            

                8.8 Polymer Factory         

                8.9 Presage Bioscience   

                8.10  QLT Inc.       

                8.11 UCB Group.                

9.Competitive Landscape 

                9.1 Market share analysis              

                9.2 Merger and Acquisition Analysis         

                9.3 Agreements, Collaborations, and Joint Ventures           

                9.4 New Product Launches           

10.Market Outlook and Investment Opportunities                            

Appendix

                a) List of Tables  

                b) List of Figures                

  1. Latin America Injectable Drug Delivery Market, By Device Type, From 2022 - 2027 (USD Million)
  2. Latin America Self-injection Devices Market, By Region, From 2022 - 2027 (USD Million)
  3. Latin America Conventional Devices Market, By Region, From 2022 - 2027 (USD Million)
  4. Latin America Injectable Drug Delivery Market, By Formulation, From 2022 - 2027 (USD Million)
  5. Latin America Conventional Drug Delivery Market, By Region, From 2022 - 2027 (USD Million)
  6. Latin America Novel Drug Delivery Market, By Region, From 2022 - 2027 (USD Million)
  7. Latin America Injectable Drug Delivery Market, By Therapeutic Use, From 2022 - 2027 (USD Million)
  8. Latin America Autoimmune Disorders Market, By Region, From 2022 - 2027 (USD Million)
  9. Latin America Hormonal Disorders Market, By Region, From 2022 - 2027 (USD Million)
  10. Latin America Oncology Market, By Region, From 2022 - 2027 (USD Million)
  11. Latin America Injectable Drug Delivery Market, By End-user, From 2022 - 2027 (USD Million)
  12. Latin America Hospitals Market, By Region, From 2022 - 2027 (USD Million)
  13. Latin America Homecare Settings Market, By Region, From 2022 - 2027 (USD Million)
  14. Latin America Research Institutes Market, By Region, From 2022 - 2027 (USD Million)
  15. Latin America Clinical Laboratories Market, By Region, From 2022 - 2027 (USD Million)
  16. Brazil Injectable Drug Delivery Market, By Device Type , From 2022 - 2027 (USD Million)
  17. Brazil Injectable Drug Delivery Market, By Formulation, From 2022 - 2027 (USD Million)
  18. Brazil Injectable Drug Delivery Market, By Therapeutic Use, From 2022 - 2027 (USD Million)
  19. Brazil Injectable Drug Delivery Market, By End-user, From 2022 - 2027 (USD Million)
  20. Argentina Injectable Drug Delivery Market, By Device Type , From 2022 - 2027 (USD Million)
  21. Argentina Injectable Drug Delivery Market, By Formulation, From 2022 - 2027 (USD Million)
  22. Argentina Injectable Drug Delivery Market, By Therapeutic Use, From 2022 - 2027 (USD Million)
  23. Argentina Injectable Drug Delivery Market, By End-user, From 2022 - 2027 (USD Million)
  24. Mexico Injectable Drug Delivery Market, By Device Type , From 2022 - 2027 (USD Million)
  25. Mexico Injectable Drug Delivery Market, By Formulation, From 2022 - 2027 (USD Million)
  26. Mexico Injectable Drug Delivery Market, By Therapeutic Use, From 2022 - 2027 (USD Million)
  27. Mexico Injectable Drug Delivery Market, By End-user, From 2022 - 2027 (USD Million)
  28. Rest of Latin America Injectable Drug Delivery Market, By Device Type , From 2022 - 2027 (USD Million)
  29. Rest of Latin America Injectable Drug Delivery Market, By Formulation, From 2022 - 2027 (USD Million)
  30. Rest of Latin America Injectable Drug Delivery Market, By Therapeutic Use, From 2022 - 2027 (USD Million)
  31. Rest of Latin America Injectable Drug Delivery Market, By End-user, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample